Polypill—even better for coronary prevention among those at high risk

LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” policy for the over-fifties irrespective of risk. Professor Simon Thom from Imperial College in London tells Sarah Maxwell about his group’s findings presented to the American Heart Association 2012 Scientific Sessions.